Print Page  |  Close Window

SEC Filings

8-K
TEVA PHARMACEUTICAL INDUSTRIES LTD filed this Form 8-K on 02/08/2018
Entire Document
 

         
Revenues by Activity and Geographical Area
(Audited)

Year Ended December 31,

Percentage
Change

Percentage
Change

2017 2016 2017 - 2016 2017 - 2016
(U.S. $ in millions) in local currencies
Generic Medicines
United States $ 5,036 $ 4,556 11% 11%
Europe 3,994 3,563 12% 11%
Rest of the World 3,227 3,871 (17%) 10%
Total Generic Medicines 12,257 11,990 2% 10%
Specialty Medicines
United States 5,686 6,724 (15%) (15%)
Europe 1,780 1,598 11% 10%
Rest of the World 448 352 27% 27%
Total Specialty 7,914 8,674 (9%) -9%
Other Revenues
United States 1,251 369 239% 239%
Europe 308 248 24% 22%
Rest of the World 655   622 5% 0%
Total Other Revenues 2,214 1,239 79% 76%
Total Revenues $ 22,385 $ 21,903 2% 6%

_______________

*In light of the political and economic conditions in Venezuela, we exclude the quarterly changes in revenues and operating profit in Venezuela from any discussion of local currency results.